Quantitative analysis for Anixa Biosciences, Inc. (ANIX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (49.0) (grade C). 29 signals analyzed (24 differentiated alt-data).
ANIX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $3.02 | $2.86 | $2.89 |
| 2026-05-11 | $3.03 | $2.93 | $3.03 |
| 2026-05-21 | $2.80 | $2.67 | $2.75 |
| 2026-06-03 | $2.66 | $2.50 | $2.52 |
| 2026-06-15 | $2.67 | $2.47 | $2.48 |
| 2026-06-26 | $2.79 | $2.36 | $2.79 |
| 2026-07-09 | $3.28 | $3.10 | $3.22 |
| 2026-07-21 | $3.70 | $3.40 | $3.56 |
| 2026-07-31 | $3.56 | $3.31 | $3.42 |
| 2026-08-12 | $3.34 | $3.20 | $3.23 |
| 2026-08-24 | $3.73 | $3.51 | $3.62 |
| 2026-09-03 | $3.25 | $2.99 | $3.05 |
How Anixa Biosciences, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| RPID | Rapid Micro Biosystems, Inc. | $91M | — |
| DTIL | Precision BioSciences, Inc. | $92M | — |
| SEER | Seer, Inc. | $92M | — |
| XGN | Exagen Inc. | $93M | — |
View all Health Care stocks by valuation and signals →
Anixa Biosciences, Inc. (ANIX) scores Hold (49.0), and the composite conceals a 69-point disagreement between its dimensions. It is strongest on analyst consensus at 99 and competitive moat at 98, and weakest on ML forecast at 37 and technicals at 30. A stock can carry analyst consensus that high while technicals sits at 30; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 99 |
| competitive moat | 98 |
| ML forecast | 37 |
| technicals | 30 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Anixa Biosciences, Inc. (ANIX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ANIX"><img src="https://stoquant.com/badge/ANIX.svg" alt="Anixa Biosciences, Inc. (ANIX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.